Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.

Source:http://linkedlifedata.com/resource/pubmed/id/18445827

J. Natl. Cancer Inst. 2008 May 7 100 9 642-8

Download in:

View as

Triples

General Info

PMID
18445827